In this work we describe and discuss the use of semiconductor massively parallel sequencing to analyze 32 STRs present on the autosomes and sex chromosomes in cell-free fetal DNA present in maternal circulation. To date we have processed more than 180 tests as routine casework. Cases involving the confirmation of paternity in which no genetic discrepancies were observed and where the paternal alleles were clearly evident in the fetal DNA always resulted in paternity indices > 1000.
Introduction
In recent years analysis of cffDNA by massive parallel sequencing (MPS) has become the standard initial procedure used to screen for fetal aneuploidies in women, starting at the 9th week of pregnancy [reviewed in [1] ]. The cffDNA can be used establish paternity prenatally, thus noninvasively avoiding chorionic villus biopsy or amniotic fluid sampling. Analyzing cffDNA in maternal plasma using MPS to determine paternity represents distinct challenges: at the 9th week of pregnancy (when most tests are requested) the average fetal fraction of all circulating DNA is 10%, and these DNA fragments comprise a mixture of both maternal-and fetal-derived molecules. Although short tandem repeat (STR) loci should be the ideal markers to analyze in this context, MPS of STR loci reveals a considerable amount of stutter which complicates the allelic assignments; additionally the average sizes of the maternal and fetal fragments are 166 and 145 bp respectively which exclude the use of some STR loci. Alternatively the typically widespread bi-allelic single nucleotide polymorphisms (SNPs) can be used as markers, thus requiring that a large number of these loci need to be analyzed. Natera, Inc. was, as far as we know, the first entity to carry out routine noninvasive prenatal paternity testing [2] : 317000 genome wide SNPs were assayed to enable the statistical inferences to be made. This service was halted and transferred to DNA Diagnostics Center (DDC) and this laboratory routinely analyzes 2688 SNPs for their testing. Other experimental accounts describing the use SNPs for noninvasive prenatal paternity testing have been reported including a more recent one involving the use of semiconductor MPS [3] . We have been evaluating both SNPs and STRs as markers to perform noninvasive prenatal paternity testing and here we explain the implementation of STRs to do this. An optimistic pilot study using STRs was outlined previously [4] and we endeavored to extend this work.
Materials and methods
Informed consent was obtained from all participants which included disclaimers emphasizing that the testing could not be reliably performed if a brother of the alleged father (AF) was the true father or if consanguinity existed between the two parents. Twenty ml venous blood was obtained from pregnant women in the 9th week or later of a singleton pregnancy (confirmed by ultrasound scan) either into EDTA tubes (for processing within 3 h) or into Cell-Free DNA BCT (Streck) if collected in another city; 100 μl was spotted onto filter paper. Following centrifugation, the plasmas were stored at −20°C or at −80°C until further use. Blood (100 μl) from the AF was collected on filter paper. Strict measures such as UV cabinets were used to minimize contamination. Circulating DNA was extracted from 5 ml plasma using QIAamp Circulating Nucleic Acid Kit (Qiagen), eluted into a final volume of 35 μl and maintained at −20°C until further use. Genomic DNA from blood on ordinary filter paper was extracted using standard methods and both the maternal and paternal DNAs were typed using an in-house multiplex PCR and capillary electrophoresis [5] . Full correspondence between the allelic designations obtained by MPS and by capillary electrophoresis was verified at the beginning of these studies.
Library preparation for MPS was begun by producing 3 pools of amplicons using PCR primers targeting the STR loci and ChrY loci listed in Table 1: The purified maternal and plasma DNAs were thawed and each subjected to the 3 PCR amplifications comprising 28 cycles in final volumes of 25 μl. For each sample 10 μl of each pool were mixed together and then processed using the Ion Plus Fragment Library Kit (Thermo Fisher) following the manufacturer's instructions. The resultant barcoded libraries were quantified using the Ion Library TaqMan Quantitation Kit and a 7500 qPCR instrument (ThermoFisher).
Each library was diluted to 9 pM and up to 3 duos (6 samples, maternal whole blood and plasma) were mixed together to give a final volume of 25 μl; in these mixtures the amount of library DNA from plasma was made to exceed that of the maternal library DNA by a factor of 7.3.
Emulsion PCR of the combined libraries and Ion Sphere particle (ISP) enrichment were carried out using the Ion PGM Hi-Q View OT2 Kit and related instruments (Thermo Fisher), and semiconductor sequencing of the ISPs was performed using the Ion PGM Hi-Q View Sequencing Kit, a 314 Chip v2 and an Ion Personal Genome Machine (Thermo Fisher) employing 500 flows; the manufacturer's instructions were followed during all steps.
The resultant data were processed on the dedicated server housing the Torrent Suite Software v5.0.5 (Thermo Fisher). After the default processing the data were usually reanalyzed with modified basecaller arguments to increase sensitivity. After reanalysis the HID_STR_Genotyper plugin v3.1 (Thermo Fisher) was run using a custom BED file written to enable assignment of the STR alleles.
Results and discussion
To date > 180 cases of noninvasive prenatal paternity testing have been performed; the first 32 cases were carried out in parallel with cases sent to DDC for validation, and for which complete concordance was observed.
For the plasma DNAs the average total coverage was 80000 reads per sample, while that for the mothers alone was 10000, giving rise to average read depths per STR locus of 800 and 110 respectively.
The key initial step in the analysis is observing the fetal fraction in the plasma by way of detecting contributions from the AF. Upon confirming this feature, the analysis can proceed to decide whether paternity is excluded or, if not, calculate a paternity index (PI) based upon the informative loci.
The main drawback of using STRs in this context is the inevitable MPS stutter 'peaks' that can easily mask the paternal alleles if they coincide, which occurs often given the typical frequency distributions of the STR alleles. This disadvantage can be overcome by using an adequate number of loci, as exemplified here. Provided that the presence of the fetal fraction has been reliably established throughout the loci, the absence of the expected paternal alleles can strengthen exclusion of paternity rather than being attributed to allele drop-out. Because MPS is relatively labour-intensive with elevated consumable costs, it can be argued that the fetal fraction should be measured before beginning the procedures, such as by using foetal-specific markers [3] . In our casework series four maternal blood redraws have been required, signifying that pre-measurement of the fetal fraction is not necessary at present. In gestations with male foetuses estimates of foetal fraction can be obtained by analysing ChrY markers present in the plasma. In fact, when the foetus is male, given the disclaimers highlighted during the informed consent, it is readily feasible to perform noninvasive prenatal paternity testing without MPS; we have always amplified purified cffDNA using the PowerPlex Y23 System (Promega) in these cases.
If no exclusionary loci are encountered, paternity is assumed to exist and a combined PI is calculated the standard formulas; however, because the plasma contains a mixture of maternal and foetal alleles, it is commonly not possible to assign the maternally inherited allele. In these situations the most conservative (lowest) PI is used taking into account the respective allele frequencies and formula. Upon analysing at least 19 autosomal STRs, a minimum combined PI of 1000 was obtained, this being the threshold used in this casework. More recently we have been evaluating the use of relMix [6] to make the statistical inferences.
We have shown that semiconductor MPS of STRs for noninvasive prenatal paternity testing can be readily adopted into laboratory workflow; beginning with sample collection, 3-6 cases can be processed in 3 working days, thus consuming 1-2 314 Chips. Despite this we have reservations concerning the use of STRs for this purpose; the stuttering results in a significant loss of information when trying to visualize the paternal alleles. It must also be pointed out that STRs sequence poorly using this technology when compared to nonrepeat DNA, as evidenced by the chip loading metrics shown by the Torrent Server software. Consequently we foresee that using MPS to analyze SNPs in novel ways is likely to be the way forward for this testing.
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